...Fanny Carolina López Jiménez; Jorge Alberto González Torres; Sirenia Castro Molina; Andrea Malagón Liceaga; Linda García Hidalgo Introduction: Kaposi’s sarcoma (KS) is a rare soft tissue tumor linked to human herpesvirus 8, a recognized oncogenic virus. Five distinct clinical presentations have...

...Serkan Yazici; Ozge Zorlu; Emel Bulbul Baskan; Saduman Balaban Adim; Kenan Aydogan; Hayriye Saricaoglu Background: Kaposi’s sarcoma (KS) is a multifocal angioproliferative tumor involving primarily the skin. Objective: The aim of this study was to describe the clinical, demographic...

...F. Brunet-Possenti; C. Pages; R. Rouzier; N. Dupin; M. Bagot; C. Lebbé We report the observation of cutaneous Kaposi's sarcoma (KS) worsening during the second trimester of pregnancy in 2 African women. Both patients were tested seronegative for HIV. They had no complication during their pregnancy...

... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Immunocompromised district Kaposi’s sarcoma Lymphedema Lymph stasis Letter...

...M. Kostaki; X.C. Pham; L. Toutous-Trellu; V. Piguet; G. Kaya; J.H.D. Fasel; B.V. Stimec; M. Becker; D. Salomon A 63-year-old Swiss patient developed acquired nodules on his right palm after 3 localized surgeries, called ‘needle fasciotomy’, for Dupuytren’s disease. Kaposi’s sarcoma (KS...

...Thaís Corsetti Grazziotin; Carlo Cota; Rosana Bortoli Buffon; Leonardo Araújo Pinto; Alessandra Latini; Marco Ardigò Background: Kaposi’s sarcoma (KS) is an unusual, clinically polymorphic, vascular neoplasm with genetic, infectious, environmental and immunological pathogenesis. Reflectance...

... months. LAS are also strong immunosuppressors and can result in severe opportunistic infections and immunodeficiency-related malignancies. However, the time needed for immune recovery after withdrawal of LAS is unknown. Here we report a case of Kaposi’s sarcoma (KS) and severe immunosuppression after...

...A. Krakowski; S. Brenner; J. Covo; M. Loewenthal; M. Baratz A case of Kaposi’s sarcoma with associated ichthyosis is presented. Kaposi’s sarcoma should probably be added to the conditions in which acquired ichthyosis is bound to occur. 1 08 1973 5 09 1973 16 10 2009 © 1973 S...

...E.J. Feuerman; S. Potruch-Eisenkraft The collected data of 38 patients with Kaposi’s sarcoma seen within 10 years (1960–1970) were analysed. 30 were males and 8 females, with 26 originating in East and Central Europe. In the majority, the disease had begun in the 5th and 6th decade. In most...

...G. Madeddu; G. Borroni; G. Rabbiosi; S. Campus 10 patients with clinical and histopathological evidence of Kaposi’s sarcoma were evaluated with 99 Tc m -pertechnetate and 67 Ga-citrate scintigraphs. Combined studies using these radionuclides are useful aids in investigating, detecting and following...

...A. Bourlond; D. Dubois; R. de Sélys Immunotherapy with interferon and transfer factor has been tried in 2 cases of Kaposi’s sarcoma of the Mediterranean type, without visceral involvement. Clinical benefits appeared almost worthless and biological data hardly improved. On the contrary, side effects...

...Michael David; Batya Shohat; Gregory Morozinski; Eleasar J. Feuerman In 20 patients with Kaposi’s sarcoma (KS) the level of B and T lymphocytes in the peripheral blood, as well as the function of T cells measured by the graft-versus-host reaction (GVHR), were investigated. Analysis of the results...

...E. Scaparro; Susanna Borghi; A. Rebora Immunosuppressed patients are at risk of acquiring Kaposi’s sarcoma. We describe a 86-year-old man who was receiving steroid therapy for bullous pemphigoid and rapidly developed Kaposi’s Sarcoma. The authors review and discuss the role of acquired...

...L. Brambilla; V. Boneschi; G. Beretta; A.F. Finzi Over a period of 36 months we treated 12 patients with skin localizations of Kaposi’s sarcoma with intralesional chemotherapy. Local administration of vincristine (usual dose 0.1 mg per site) or bleomycin appeared to be very effective: in 93...

...Zbigniew Ruszczak; Augusto Mayer da Silva; Constantin E. Orfanos In clinically noninvolved skin from the area surrounding early macular lesions of AIDS-associated disseminated Kaposi’s sarcoma (KS), morphological evidence of vascular proliferation was seen in the upper papillary dermis. Poorly...

...S. Weltfriend; R. Friedman-Birnbaum; S. Pollack Natural killer (NK) cell activity of peripheral blood lymphocytes was evaluated in a group of 13 patients with classical Kaposi’s sarcoma (KS). All patients had a normal T4/T8 ratio, and the disease was confined to the skin of the lower extremities...

...D.L. Crosby; T.G. Berger; J.T. Woosley; S.D. Resnick Kaposi’s sarcoma (KS) is an important finding in patients infected with human immunodeficiency virus (HIV), with a distinctive spectrum of clinical presentations. Three cases of dermatophytosis in HIV-infected patients are presented which...

...Rachel Friedman-Birnbaum; Sara Weltfriend; Ilan Katz The records of 67 Israeli patients with classical Kaposi’s sarcoma treated at Rambam Medical Center were analyzed retrospectively for clinical and laboratory data. As expected, all except 1 patient were of Jewish origin. There was a male...

...R.A. Schwartz; M.S. Spicer; C.K. Janniger; P.J. Cohen; M.M. Melczer; W.C. Lambert Kaposi’s sarcoma is a unique neoplasm which has emerged as an important element of AIDS in homosexuals but not in others at high risk for AIDS. The biology of this important tumor may be related to cytokines secreted...

...M. Lospalluti; M. Mastrolonardo; F. Loconsole; A. Conte; F. Rantuccio Background : Classical Kaposi’s sarcoma (KS) is a sporadic disease that is particularly prevalent in Mediterranean countries. Objective : The aim of the study was to update clinical information about this rare condition. Methods...